University of Wisconsin–Madison news, November 30, 2017 By David Tenenbaum.
Using a molecule designed to overcome a roadblock formed by a common type of genetic flaw, researchers at the University of Wisconsin–Madison have made progress towards novel molecular treatments for Friedreich’s ataxia — a rare but fatal disorder — in the laboratory dish and in animals.
Designer molecule points to treatment for diseases caused by DNA repeats